Src as a potential therapeutic target in non-small-cell lung cancer. (Q37128267)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388349%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Src as a potential therapeutic target in non-small-cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388349%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388349%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

P A Zucali

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388349%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

3 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388349%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388349%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388349%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388349%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

1219-1223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388349%20AND%20SRC:MED&resulttype=core&format=json

Estimates of the cancer incidence and mortality in Europe in 2006.

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

PTP alpha regulates integrin-stimulated FAK autophosphorylation and cytoskeletal rearrangement in cell spreading and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Src family kinases in tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Selected glimpses into the activation and function of Src kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Structural differences between repressed and derepressed forms of p60c-src

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Role of Src expression and activation in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

pp60c-src activation in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Prostaglandin E2 activates Src signaling in lung adenocarcinoma cell via EP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Inducible expression of endothelial PAS domain protein-1 by hypoxia in human lung adenocarcinoma A549 cells. Role of Src family kinases-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Mechanism of biological synergy between cellular Src and epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Src promotes destruction of c-Cbl: implications for oncogenic synergy between Src and growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

SRC tyrosine kinase inhibitor, m475271, suppresses subcutaneous growth and production of lung metastasis via inhibition of proliferation, invasion, and vascularization of human lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN048

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDN048

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18388349%20AND%20SRC:MED&resulttype=core&format=json

release_47u3udroprgy7jsfy77eyscakm

5 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/47u3udroprgy7jsfy77eyscakm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference